Pfizer Reports Second-Quarter 2023 Results
Second-Quarter 2023 Revenues of $12.7 Billion– Expected Decline in Paxlovid and Comirnaty(1) Revenues Drove 53% Operational Decrease in SecondQuarter 2023 Revenues– Second-Quarter 2023 Revenues from Comirnaty(1) and Paxlovid of $1.6 Billion– Excluding Contributions from Comirnaty(1) and Paxlovid, Revenues Grew 5%…
U.S. FDA Approves Merck’s ERVEBO® (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for ERVEBO, which is now indicated for the prevention of disease caused…
Chemed Corporation Declares Quarterly Dividend of 40 Cents
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company’s capital stock, payable on September 5, 2023, to shareholders of record as of August 14, 2023. This is a 2-cent, or 5.3%, increase…
CENTENE RANKS NO. 60 ON FORTUNE’S 2023 GLOBAL 500 LIST
Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it has been named to Fortune’s “Global 500” for 2023, the annual ranking of the top 500 companies worldwide by total revenue. Centene first made the…
McKesson Medical-Surgical Supports National Health Center Week 2023
McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will participate as a silver sponsor of the National Association of Community Health Centers National Health Center Week 2023 (NHCW) Aug. 6-12. The theme of NHCW 2023 is “Community Health Centers: The…
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the third quarter of fiscal 2023 ended June 30, 2023. “We…
Owens & Minor Reports Second Quarter 2023 Financial Results
Owens & Minor, Inc. (NYSE: OMI)today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: “The second quarter of 2023 shows a continuation of our Patient Direct segment’s exceptional performance, with another quarter of…
TigerConnect® Named a Leader in the 2023 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration
TigerConnect, healthcare’s most trusted clinical collaboration platform, today announced it has been named a Leader in the 2023 Gartner Magic Quadrant for Clinical Communication and Collaboration (CC&C). The evaluation was based on inclusion criteria that included platforms’ competitive product offerings…
Owens & Minor Reports Second Quarter 2023 Financial Results
Owens & Minor, Inc. (NYSE: OMI)today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: “The second quarter of 2023 shows a continuation of our Patient Direct segment’s exceptional performance, with another quarter of…
Tivic Health Announces Pricing of $1.4 Million Public Offering of Common Stock
Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its previously announced public offering of 33,173,000 shares of its common stock at a public offering price…
FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder
Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) approved ZURZUVAETM (zuranolone) 50 mg for adults with postpartum depression (PPD). ZURZUVAE is the first and only oral, once-daily, 14-day treatment that can provide rapid…
United States Direct-To-Consumer Genetic Testing Market Analysis Report 2023-2028: Personalized Genetic Testing Services Fuels Market Expansion – ResearchAndMarkets.com
The United States Direct-To-Consumer Genetic Testing Market is expected to grow at a significant rate to 2028 During the forecast period, rising public awareness of the accessibility of direct-to-consumer genetic tests in both developed and developing countries will fuel market…